These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


78 related items for PubMed ID: 4344784

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical and laboratory evaluation of cephalexin in urinary-tract infections.
    Acar JF, Baudens JG, Chabbert YA.
    Antimicrob Agents Chemother (Bethesda); 1969; 9():398-404. PubMed ID: 4919001
    [No Abstract] [Full Text] [Related]

  • 4. Laboratory and clinical evaluation of rifampicin.
    Atlas E, Turck M.
    Am J Med Sci; 1968 Oct; 256(4):47-54. PubMed ID: 4387028
    [No Abstract] [Full Text] [Related]

  • 5. [On the effect of hexetidine in vitro].
    Linzenmeier G.
    Arzneimittelforschung; 1969 Feb; 19(2):164-7. PubMed ID: 4388760
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cephaloridine: antimicrobial activity and pharmacologic behavior.
    Kaplan K, Reisberg BE, Weinstein L.
    Am J Med Sci; 1967 Jun; 253(6):667-74. PubMed ID: 4381751
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Behavior of indanyl-carbenicillin (CP 15,464) following oral administration in man].
    Burgy C.
    Schweiz Med Wochenschr; 1972 May 27; 102(21):732-8. PubMed ID: 4630209
    [No Abstract] [Full Text] [Related]

  • 11. [Gentamicin: antibacterial activity in vitro and clinical studies].
    Altucci P, Sapio U, Varone GL.
    Minerva Med; 1967 Nov 28; 58(95 Suppl):4208-11. PubMed ID: 4966210
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization.
    Sabath LD, Gerstein DA, Loder PB, Finland M.
    J Lab Clin Med; 1968 Dec 28; 72(6):916-23. PubMed ID: 4972710
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and bacteriological evaluation of intravenous doxycycline in severe hospital infections.
    Klastersky J, Cappel R, Rens B, Daneau D.
    Curr Ther Res Clin Exp; 1972 Feb 28; 14(2):49-60. PubMed ID: 4401232
    [No Abstract] [Full Text] [Related]

  • 18. [Bacteriological and pharmacological properties of new cephalosperine antibiotics. II. Cephaloridine].
    Naumann P.
    Arzneimittelforschung; 1967 Apr 28; 17(4):469-81. PubMed ID: 4386771
    [No Abstract] [Full Text] [Related]

  • 19. [Studies on the compounds related to colistin. V. Synthesis and pharmacological activity of colistin analogues].
    Kurihara T, Takeda H, Ito H.
    Yakugaku Zasshi; 1972 Feb 28; 92(2):129-34. PubMed ID: 4624024
    [No Abstract] [Full Text] [Related]

  • 20. Review of bacteriology and preclinical studies and clinical pharmacology of gentamicin sulfate.
    Falco FG.
    Ther Umsch; 1969 Jan 28; ():Suppl:8-16. PubMed ID: 4977957
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.